Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT05663866 2026-04-13

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

Phase 2 Active not recruiting

68 enrolled 12 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05986318 2026-03-09

RESPIRE-ILD

Phase 2 Recruiting

98 enrolled

Thoracic

Lung Neoplasms, Lung Diseases, Interstitial, Radiation Pneumonitis

NCT06974604 2025-10-24

Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

Phase 2 Recruiting

60 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Triple Negative Breast Neoplasms

NCT04265534 2022-09-21

KEAPSAKE

Phase 2 Terminated

40 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04267913 2020-11-20

Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)

Phase 2 Withdrawn

Thoracic

Lung Neoplasms

NCT04001725 2019-11-13

OPTIMAL

Phase 2 Unknown

110 enrolled

BreastCNSDermatologicThoracic

Brain Neoplasms, Breast Neoplasms, Diabetes Mellitus, Lung Neoplasms, Melanoma, Neoplasms

NCT01165021 2019-09-25

A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer

Phase 2 Completed

19 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02410382 2019-05-14

Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer

Phase 2 Terminated

79 enrolled

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Neoplasms

NCT00227019 2017-03-06

Phase 2 Trial of Bevacizumab in Combination With Pemetrexed

Phase 2 Completed

16 enrolled 9 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT01194453 2016-06-16

AP/GP

Phase 2 Completed

288 enrolled 8 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02445872 2015-12-09

Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

Phase 2 Unknown

80 enrolled

Thoracic

Lung Neoplasms, Nausea, Vomiting

NCT00247416 2014-03-07

Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer

Phase 2 Completed

60 enrolled 10 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01569919 2013-03-12

SKOPOS

Phase 2 Unknown

26 enrolled

Other solid neoplasmThoracic

Mesothelioma

NCT00609518 2010-12-28

A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer

Phase 2 Completed

111 enrolled 17 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00215748 2007-11-16

Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel

Phase 2 Terminated

40 enrolled

BreastThoracic

Breast Neoplasms, Lung Neoplasms

Clinical Trials

MK-3475-01E

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

RESPIRE-ILD

Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

KEAPSAKE

Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)

OPTIMAL

A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer

Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer

Phase 2 Trial of Bevacizumab in Combination With Pemetrexed

AP/GP

Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer

SKOPOS

A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer

Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel